EULAR 2026… EULAR 2026: Do Not Miss- SLE & APS 24 May 20261 Jun 2026 Daliya Pencheva Daliya Pencheva is a rheumatologist at the Clinic of Rheumatology, University Hospital “St. Ivan Rilski”, Sofia, Bulgaria. She obtained her PhD from the Medical University of Sofia with…
EULAR 2025 highlights… EULAR 2025 Highlights – SLE and APS 18 Jul 2025 Preliminary results of CD19/BCMA Dual-Targeting FasTCAR-T Cells GC012F (AZD0120) in patients with refractory Systemic Lupus Erythematosus-an open-label, single-arm study Abstract format and assignment number: Oral presentation OP0074 Date: Wednesday, 11…
SLE & APS EULAR 2025: Do Not Miss –SLE & APS 1 Jun 20259 Jun 2025 Claudia IannoneCountry: Italy Claudia is a Rheumatology resident at Milan University, carrying out her research at Gaetano-Pini Hospital in Milan, Italy. Her research interests are focused systemic sclerosis, interstital lung…
ACR Highlights… ACR Convergence 2024 Highlights – SLE and APS 19 Dec 202419 Dec 2024 A Novel, Potent and Selective TLR7/8 Small Molecule Inhibitor Blocks TLR7/8 Pathway in the Presence of HCQ and Demonstrates Robust Preclinical Efficacy in Lupus Models Abstract format and assignment number:…
ACR Congress Do Not Miss… ACR Convergence 2024: Do Not Miss – SLE & APS 5 Nov 20246 Nov 2024 Daliya PenchevaDaliya is a rheumatologist at the Clinic of Rheumatology, University Hospital "St. Ivan Rilski," Sofia, Bulgaria. She obtained her PhD from the Medical University of Sofia, Bulgaria, with a…
EULAR 2024 Highlights… EULAR 2024 Highlights – SLE and APS 21 Jul 202422 Jul 2024 Author: Cristiana Sieiro Santos Taubmann et al. (OP0027) presented data on the long-term safety and efficacy of autologous CD19 CAR T cell therapy in patients with SLE, IIM and SSc, showing that…
SLE & APS EULAR 2024: Do Not Miss –SLE & APS 8 Jun 202421 Jul 2024 Cristiana Sieiro Santos Cristiana is a rheumatology consultant at Complejo Asistencial Universitario de León (Spain) focusing on SLE and SSc, currently responsible for a nailfoldvideocapillaroscopy and ILD-associated CTD outpatient clinic. She is a PhD student of the Doctoral Program of Biomedical Sciences focusing on the immuneresponses to conventional vaccines in patients with immune-mediated diseases. Oral 0208 |…
ACR Highlights… ACR Convergence Highlights 2023 – SLE and APS 9 Dec 20239 Dec 2023 Author: Anastasia Madenidou Schett et al. (0607) followed up 8 SLE patients who received treatment with CD19 CAR T cell therapy. Five patients had a follow-up of more than one year…
ACR Congress Do Not Miss… ACR Convergence 2023: Do Not Miss – SLE & APS 6 Nov 2023 Daliya PenchevaDaliya is a rheumatology resident at the University Hospital “St. Ivan Rilski”, Sofia, Bulgaria. Her major interests are systemic lupus erythematosus, quality of life, patient-reported outcome measures, treat-to-target therapy.…
SLE & APS [EULAR HL 2023] SLE & APS 30 Jun 202330 Jun 2023 Author: Mert Oztas Schett et al. (OP0141) presents the long-term clinical efficacy and safety data of the first seven SLE patients (median follow up of 13 months) receiving autologous CD19-directed CAR-T cell…